Literature DB >> 24675008

Relationships between mild hyperuricaemia and aortic stiffness in untreated hypertensive patients.

G Mulè1, R Riccobene2, A Castiglia2, F D'Ignoto2, E Ajello2, G Geraci2, L Guarino2, E Nardi2, F Vaccaro2, G Cerasola2, S Cottone2.   

Abstract

BACKGROUND AND AIMS: Clinical studies exploring the relationship between serum uric acid (SUA) and arterial stiffness yielded conflicting results. Only in a few of these studies, arterial distensibility was examined by measuring aortic pulse wave velocity (PWV), which is considered the gold standard for evaluating arterial stiffness. In none of the previous investigations was the influence of SUA on aortic distensibility assessed, taking into account the effect of albuminuria. The purpose of our study was to comprehensively analyse the relationships between SUA and aortic PWV in a group of essential hypertensive patients. METHODS AND
RESULTS: We enrolled 222 untreated and uncomplicated hypertensive subjects (mean age: 44 ± 10 years; 60% males), without gout. In all patients, SUA and urinary albumin excretion rate (AER) were determined. Moreover, carotid-femoral (c-f) PWV was measured. C-f PWV was significantly higher in hypertensive patients belonging to the uppermost tertile of SUA distribution, compared to subjects of the lowest tertiles (10.9 ± 2.2 vs. 10 ± 1.8 vs. 9.9 ± 1.7 m s(-1); p = 0.001). In univariate analysis, SUA correlated with c-f PWV (r = 0.24; p < 0.001). This association disappeared when AER was added in a multiple regression model, including SUA, age, mean arterial pressure, gender, metabolic syndrome components and glomerular filtration rate.
CONCLUSION: The results of our study showed that, in essential hypertensive subjects, there is a positive relationship between mild hyperuricaemia and aortic stiffness. This association weakened after adjustment for covariates and lost statistical significance after further correction for albuminuria.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aortic stiffness; Arteriosclerosis; Essential hypertension; Pulse wave velocity; Serum uric acid

Mesh:

Substances:

Year:  2014        PMID: 24675008     DOI: 10.1016/j.numecd.2014.01.014

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  14 in total

1.  Association between self-reported snoring and arterial stiffness: data from the Brisighella Heart Study.

Authors:  Arrigo F G Cicero; Martino Morbini; Riccardo Urso; Martina Rosticci; Angelo Parini; Elisa Grandi; Sergio D'Addato; Claudio Borghi
Journal:  Intern Emerg Med       Date:  2015-09-28       Impact factor: 3.397

Review 2.  Metabolic syndrome in hypertensive patients: An unholy alliance.

Authors:  Giuseppe Mulè; Ilenia Calcaterra; Emilio Nardi; Giovanni Cerasola; Santina Cottone
Journal:  World J Cardiol       Date:  2014-09-26

3.  Uric acid blood levels and relationship with the components of metabolic syndrome in hypertensive patients.

Authors:  M V Papavasileiou; A G Karamanou; P Kalogeropoulos; G Moustakas; S Patsianis; A Pittaras
Journal:  J Hum Hypertens       Date:  2015-07-02       Impact factor: 3.012

Review 4.  Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project.

Authors:  Alessandro Maloberti; C Giannattasio; M Bombelli; G Desideri; A F G Cicero; M L Muiesan; E A Rosei; M Salvetti; A Ungar; G Rivasi; R Pontremoli; F Viazzi; R Facchetti; C Ferri; B Bernardino; F Galletti; L D'Elia; P Palatini; E Casiglia; V Tikhonoff; C M Barbagallo; P Verdecchia; S Masi; F Mallamaci; M Cirillo; M Rattazzi; P Pauletto; P Cirillo; L Gesualdo; A Mazza; M Volpe; G Tocci; G Iaccarino; P Nazzaro; L Lippa; G Parati; R Dell'Oro; F Quarti-Trevano; G Grassi; A Virdis; C Borghi
Journal:  High Blood Press Cardiovasc Prev       Date:  2020-03-10

5.  Longitudinal Association Between Serum Uric Acid and Arterial Stiffness: Results From the Baltimore Longitudinal Study of Aging.

Authors:  Marco Canepa; Francesca Viazzi; James B Strait; Pietro Ameri; Roberto Pontremoli; Claudio Brunelli; Stephanie Studenski; Luigi Ferrucci; Edward G Lakatta; Majd AlGhatrif
Journal:  Hypertension       Date:  2016-12-12       Impact factor: 10.190

6.  Pulse wave velocity progression over a medium-term follow-up in hypertensives: Focus on uric acid.

Authors:  Alessandro Maloberti; Paola Rebora; Anita Andreano; Paola Vallerio; Benedetta De Chiara; Stefano Signorini; Marco Casati; Silvia Besana; Michele Bombelli; Guido Grassi; Maria Grazia Valsecchi; Cristina Giannattasio
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-06-21       Impact factor: 3.738

7.  Relationship Between Short-Term Blood Pressure Variability and Subclinical Renal Damage in Essential Hypertensive Patients.

Authors:  Giuseppe Mulè; Ilenia Calcaterra; Miriam Costanzo; Giulio Geraci; Laura Guarino; Anna C Foraci; Maria G Vario; Giovanni Cerasola; Santina Cottone
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-23       Impact factor: 3.738

8.  Plasma uric acid is related to large arterial stiffness but not to other hemodynamic variables: a study in 606 normotensive and never-medicated hypertensive subjects.

Authors:  Humam Hamid; Venla Kurra; Manoj Kumar Choudhary; Heidi Bouquin; Onni Niemelä; Mika A P Kähönen; Jukka T Mustonen; Ilkka H Pörsti; Jenni K Koskela
Journal:  BMC Cardiovasc Disord       Date:  2021-05-26       Impact factor: 2.298

9.  Relation of serum uric acid to an exaggerated systolic blood pressure response to exercise testing in men with normotension.

Authors:  Sae Young Jae; Kanokwan Bunsawat; Yoon-Ho Choi; Yeon Soo Kim; Rhian M Touyz; Jeong Bae Park; Barry A Franklin
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-02-19       Impact factor: 3.738

10.  Association Between Uric Acid and Renal Hemodynamics: Pathophysiological Implications for Renal Damage in Hypertensive Patients.

Authors:  Giulio Geraci; Giuseppe Mulè; Manuela Mogavero; Calogero Geraci; Emilio Nardi; Santina Cottone
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-03-25       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.